Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCMWQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,021
Award facts
- Contract value 100% obligated
- $41,020.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,020.75 to DMS Pharmaceutical Group Inc. for the supply of Keytruda 100 mg/4 ml vials on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents procurement of a branded oncology pharmaceutical product to support military healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, leveraging its competitive capabilities in the federal pharmaceutical marketplace.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables DLA to procure comprehensive pharmaceutical products and medical supplies for military health facilities worldwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide, with a robust portfolio of prior contract awards for specialty medications and medical products supporting military medical operations.
Quick answers
Who was awarded contract SPE2DB25FCMWQ?
SPE2DB25FCMWQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FCMWQ worth?
The government has obligated $41,021 on SPE2DB25FCMWQ.
Is contract SPE2DB25FCMWQ an order under another contract?
Yes. SPE2DB25FCMWQ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMWQ competed?
The extent of competition for SPE2DB25FCMWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award